Lotus Pharm vs SunMax Biotechnology: monthly revenue

Monthly revenue and year-on-year change for Lotus Pharm (1795) and SunMax Biotechnology (4728) over the past 13 months. The chart compares year-on-year growth rather than amounts, since the companies differ in size.

Year-on-year change

━ Lotus Pharm ━ SunMax Biotechnology

0%+226%-30%25/1026/0126/0426/0726/10

Monthly revenue history

MonthLotus PharmYoYSunMax BiotechnologyYoY
Oct 2026NT$2.13 billion-22.5%NT$190.3 million+18.2%
Sep 2026NT$2.77 billion+128.0%NT$238.8 million+16.1%
Aug 2026NT$2.11 billion+81.7%NT$223.2 million+48.8%
Jul 2026NT$2.49 billion+3.9%NT$221.5 million+49.7%
Jun 2026NT$3.4 billion+225.5%NT$224.8 million+50.1%
May 2026NT$2.32 billion+105.8%NT$191.3 million+23.8%
Apr 2026NT$3.09 billion+19.9%NT$202.1 million+29.7%
Mar 2026NT$4.35 billion+173.6%NT$225.3 million+20.1%
Feb 2026NT$2.24 billion+131.5%NT$115.1 million-30.3%
Jan 2026NT$2.05 billion-5.5%NT$224.4 million+11.4%
Dec 2025NT$2.44 billion+66.9%NT$179.1 million+20.2%
Nov 2025NT$1.06 billion-0.2%NT$168.2 million+21.6%
Oct 2025NT$2.75 billion+46.0%NT$161 million+1.6%

← All Taiwan listed & OTC companies

Sources: Taiwan Stock Exchange, monthly revenue of listed companies (Government Open Data Platform); Taipei Exchange, monthly revenue of OTC companies (TPEx OpenAPI); historical months from MOPS. Amounts in New Taiwan dollars. Changes calculated by this site from the source figures. Not investment advice. Updated: 2026-11-16